- Introduction
- Non-Systematically Absorbed Oral Drug Products
- Topical dosage forms: Manufacture and Regulatory Issue
- Topical Dosage Forms: Bioequivalence Assessment
- Suppositories
- Nasal and Inhalation Products: Manufacture
- Nasal and Inhalation Drug Products – Regulatory and Bioequivalence
- Transdermal Drug Delivery
- Modified Release Parenteral Products
- Generic Biologies: Manufacture
- Generic Biologies: Regulatory Issues
Dr. Shargel is President, Applied Biopharmaceutics, Raleigh, NC and Affiliate Associate Professor, School of Pharmacy, Virginia Commonwealth University, Richmond, and was previously Vice President, Biopharmaceutics for Sandoz, Inc. (formerly Eon Labs). He received his B.Sc. in Pharmacy and graduated Cum Laude from the University of Maryland, Baltimore, and his Ph.D. in Pharmacology with minors in Biochemistry and Drug Metabolism from George Washington University, Medical Center, Washington D.C. Besides being a licensed pharmacist, Dr. Shargel has published several major textbooks within the subject of pharmaceutical science, and has written over 100 papers and chapters specific to the field. Dr. Shargel serves on the USP Biopharmaceutics Expert Committee, and is actively involved in teaching and consulting activities.
Dr. Kanfer is Professor of Pharmaceutics and the Dean and Head of the Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa. He has been Visiting Professor at the University of California, San Francisco and also at the University of North Carolina, Chapel Hill and spent several years in the pharmaceutical industry in Canada. Dr. Kanfer has written several book chapters and has contributed over 100 research publications and conference presentations in the areas of biopharmaceutics, bioavailability / bioequivalence and bioanalytical analysis. Dr. Kanfer has served on the editorial advisory board of the European Journal of Pharmaceutical Sciences and currently serves on the editorial board of the Journal of Pharmaceutical and Biomedical Analysis and is an associate editor of the Journal of Pharmacy and Pharmaceutical Sciences. He is a foundation member and past Chairman of the South African Academy of Pharmaceutical Sciences, a charter member of the American Association of Pharmaceutical Scientists, and has served on the Executive Committee of the Canadian Society for Pharmaceutical Sciences. He received his B.Sc.(Pharm), B.Sc.(Honours) and Ph.D. degrees from Rhodes University, South Africa.
Dr. Kanfer is Professor of Pharmaceutics and the Dean and Head of the Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa. He has been Visiting Professor at the University of California, San Francisco and also at the University of North Carolina, Chapel Hill and spent several years in the pharmaceutical industry in Canada. Dr. Kanfer has written several book chapters and has contributed over 100 research publications and conference presentations in the areas of biopharmaceutics, bioavailability / bioequivalence and bioanalytical analysis. Dr. Kanfer has served on the editorial advisory board of the European Journal of Pharmaceutical Sciences and currently serves on the editorial board of the Journal of Pharmaceutical and Biomedical Analysis and is an associate editor of the Journal of Pharmacy and Pharmaceutical Sciences. He is a foundation member and past Chairman of the South African Academy of Pharmaceutical Sciences, a charter member of the American Association of Pharmaceutical Scientists, and has served on the Executive Committee of the Canadian Society for Pharmaceutical Sciences. He received his B.Sc.(Pharm), B.Sc.(Honours) and Ph.D. degrees from Rhodes University, South Africa.
"This is a must for pharmaceutical researchers who are involved in developing generic specialty products with proven bioequivalence." - Doody's Book Review Service
